
Karista
Description
Karista is an independent venture capital firm headquartered in Paris, France, dedicated to investing in early-stage, innovative companies poised for high growth. With a strategic focus on sectors such as Health, Digital, Tech, and NewSpace, Karista aims to identify and nurture disruptive technologies and business models. The firm positions itself as a long-term partner, providing not only capital but also strategic guidance and operational support to its portfolio companies as they scale.
Karista's investment strategy targets initial funding rounds, typically deploying first cheques ranging from approximately $540,000 (€500,000) to $5.4 million (€5 million). This flexible approach allows them to support a diverse array of startups, from seed to Series A stages. Beyond the initial investment, Karista demonstrates a strong commitment to its portfolio by reserving significant capital for follow-on rounds, with the capacity to invest up to $16.2 million (€15 million) per company throughout its lifecycle. This enables them to support their ventures through multiple growth phases, ensuring sustained development and market penetration.
Since its inception, Karista has established a robust presence in the European venture capital ecosystem. The firm has successfully raised and managed several funds, including CapDecisif Management, accumulating a total of over $432 million (€400 million) in capital under management. This substantial financial backing underscores Karista's capability to make impactful investments and contribute significantly to the innovation landscape. Their portfolio reflects a commitment to pioneering companies that are shaping the future across their target industries, solidifying their reputation as a key player in early-stage tech and health investments in France and beyond.
Investor Profile
Karista has backed more than 145 startups, with 5 new investments in the last 12 months alone. The firm has led 22 rounds, about 15% of its total and boasts 31 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series B rounds (top funding stages).
- Majority of deals are located in France, United States, Germany.
- Strong thematic focus on Software, Biotechnology, Health Care.
- Led 1 rounds in the past year.
- Typical check size: $540K – $5.4M.
Stage Focus
- Seed (44%)
- Series A (22%)
- Series B (14%)
- Series Unknown (12%)
- Series C (3%)
- Convertible Note (3%)
- Angel (1%)
- Pre Seed (1%)
Country Focus
- France (86%)
- United States (8%)
- Germany (2%)
- Switzerland (1%)
- Estonia (1%)
- Norway (1%)
- Belgium (1%)
Industry Focus
- Software
- Biotechnology
- Health Care
- Information Technology
- Medical Device
- Medical
- Artificial Intelligence (Ai)
- Saas
- Manufacturing
- Therapeutics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.